Genertec Universal Medical Group Company Limited Market Cap ($1.00 Billion)
Market Cap & Net Worth: Genertec Universal Medical Group Company Limited (5UM)
Genertec Universal Medical Group Company Limited market cap. Genertec Universal Medical Group Company Limited (F:5UM) has a market capitalization of $1.00 Billion (€857.98 Million) as of November 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #8539 globally and #1136 in its home market, demonstrating a 0.41% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genertec Universal Medical Group Company Limited's stock price €0.49 by its total outstanding shares 2014204924 (2.01 Billion). Also see Genertec Universal Medical Group Company operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Genertec Universal Medical Group Company Limited Market Cap History (2015–2026)
Genertec Universal Medical Group Company Limited market cap history from 2015 to 2026. Data shows growth from $103.61 Million to $1.16 Billion (24.63% CAGR). Check current stock price of Genertec Universal Medical Group Company for real-time trading data and today's change.
Genertec Universal Medical Group Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genertec Universal Medical Group Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Genertec Universal Medical Group Company to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.10x
Genertec Universal Medical Group Company Limited's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.67x
Genertec Universal Medical Group Company Limited's market cap is 0.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $145.53 Million | $2.70 Billion | $872.31 Million | 0.05x | 0.17x |
| 2017 | $192.15 Million | $3.42 Billion | $1.15 Billion | 0.06x | 0.17x |
| 2018 | $231.01 Million | $4.30 Billion | $1.35 Billion | 0.05x | 0.17x |
| 2019 | $402.67 Million | $6.82 Billion | $1.59 Billion | 0.06x | 0.25x |
| 2020 | $826.31 Million | $8.52 Billion | $1.75 Billion | 0.10x | 0.47x |
| 2021 | $1.41 Billion | $9.91 Billion | $1.95 Billion | 0.14x | 0.73x |
| 2022 | $1.30 Billion | $11.91 Billion | $1.96 Billion | 0.11x | 0.66x |
| 2023 | $1.18 Billion | $13.65 Billion | $2.11 Billion | 0.09x | 0.56x |
| 2024 | $1.35 Billion | $13.66 Billion | $2.10 Billion | 0.10x | 0.64x |
| 2025 | $1.47 Billion | $14.94 Billion | $2.21 Billion | 0.10x | 0.67x |
Competitor Companies of 5UM by Market Capitalization
Companies near Genertec Universal Medical Group Company Limited in the global market cap rankings as of November 2, 2026. Also see Genertec Universal Medical Group Company total assets for a full breakdown of the balance sheet.
Key companies related to Genertec Universal Medical Group Company Limited by market ranking:
- Visa Inc. Class A (NYSE:V): Ranked #25 globally with a market cap of $676.80 Billion USD.
- Mastercard Inc (NYSE:MA): Ranked #34 globally with a market cap of $429.87 Billion USD.
- American Express Company (NYSE:AXP): Ranked #94 globally with a market cap of $215.64 Billion USD.
- Capital One Financial Corporation (NYSE:COF): Ranked #192 globally with a market cap of $125.67 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #25 | Visa Inc. Class A | NYSE:V | $676.80 Billion | $413.59 |
| #34 | Mastercard Inc | NYSE:MA | $429.87 Billion | $638.01 |
| #94 | American Express Company | NYSE:AXP | $215.64 Billion | $319.11 |
| #192 | Capital One Financial Corporation | NYSE:COF | $125.67 Billion | $204.85 |
Market Capitalization of Genertec Universal Medical Group Company Limited (2015–2026)
Market capitalization of Genertec Universal Medical Group Company Limited from 2015 to today. Between 2015 and today, Genertec Universal Medical Group Company Limited's market cap moved from $103.61 Million to $ 1.16 Billion, with a yearly change of 24.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.16 Billion | -21.28% |
| 2025 | €1.47 Billion | +8.70% |
| 2024 | €1.35 Billion | +15.00% |
| 2023 | €1.18 Billion | -9.09% |
| 2022 | €1.30 Billion | -8.33% |
| 2021 | €1.41 Billion | +70.99% |
| 2020 | €826.31 Million | +105.20% |
| 2019 | €402.67 Million | +74.31% |
| 2018 | €231.01 Million | +20.22% |
| 2017 | €192.15 Million | +32.04% |
| 2016 | €145.53 Million | +40.45% |
| 2015 | €103.61 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of Genertec Universal Medical Group Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.00 Billion USD |
| MoneyControl | $1.00 Billion USD |
| MarketWatch | $1.00 Billion USD |
| marketcap.company | $1.00 Billion USD |
| Reuters | $1.00 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment inc… Read more